Suppr超能文献

大鼠肝脏酰基辅酶A:胆固醇酰基转移酶:其体内调节及体外某些特性

Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro.

作者信息

Erickson S K, Shrewsbury M A, Brooks C, Meyer D J

出版信息

J Lipid Res. 1980 Sep;21(7):930-41.

PMID:7441061
Abstract

To gain insight into the role of the enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT) in cellular cholesterol homeostasis, its regulation in rat liver was investigated both in vivo and in vitro. In vitro assay conditions were optimized and some properties of the microsomal enzyme in vitro was also studied. Arrhenius plots of microsomal ACAT activity showed discontinuities at about 28-29 degrees C and 16-17 degrees C. Detergents above their critical micelle concentrations and organic solvents both inhibited the enzyme. Addition of progesterone or SC 31769, a 7-keto-cholesterol analogue, to microsomes inhibited activity while addition of 25-hydroxycholesterol increased the rate of cholesterol esterification, suggesting that the enzyme is susceptible to both negative and positive modulation by steroids, steroid analogues, or their metabolic products. Increasing the rate of cholesterol biosynthesis had a variable effect on ACAT activity. It was higher at the circadian peak of sterol biosynthesis than at the nadir. Increasing sterol biosynthesis by intragastric administration of mevalonolactone resulted in increased activity. In contrast, increasing the rate of sterol biosynthesis by feeding cholestyramine or administration of Triton WR 1339 had little effect on ACAT. Increasing hepatic cholesterol content by feeding cholesterol, cholate, or an atherogenic diet, fasting or intragastric administration of mevalonolactone all resulted in increased ACAT activity. ACAT activity showed a positive correlation with changes in microsomal free and esterified cholesterol contents. The response of ACAT to changes in hepatic cholesterol concentration in vivo and its response to changes in the rate of cholesterol synthesis support the hypothesis that this enzyme plays an important role in maintenance of hepatic cholesterol homeostasis.

摘要

为深入了解酰基辅酶A:胆固醇酰基转移酶(ACAT)在细胞胆固醇稳态中的作用,对其在大鼠肝脏中的调节进行了体内和体外研究。优化了体外测定条件,并研究了微粒体酶在体外的一些特性。微粒体ACAT活性的阿累尼乌斯图在约28 - 29℃和16 - 17℃处出现不连续。高于其临界胶束浓度的去污剂和有机溶剂均抑制该酶。向微粒体中添加孕酮或7-酮胆固醇类似物SC 31769会抑制活性,而添加25-羟基胆固醇会增加胆固醇酯化速率,这表明该酶易受类固醇、类固醇类似物或其代谢产物的正负调节。增加胆固醇生物合成速率对ACAT活性有不同影响。在甾醇生物合成的昼夜高峰时比在最低点时更高。通过胃内给予甲羟戊酸内酯增加甾醇生物合成会导致活性增加。相反,通过喂食消胆胺或给予Triton WR 1339增加甾醇生物合成速率对ACAT影响很小。通过喂食胆固醇、胆酸盐或致动脉粥样化饮食、禁食或胃内给予甲羟戊酸内酯增加肝脏胆固醇含量均导致ACAT活性增加。ACAT活性与微粒体游离和酯化胆固醇含量的变化呈正相关。ACAT对体内肝脏胆固醇浓度变化的反应及其对胆固醇合成速率变化的反应支持了该酶在维持肝脏胆固醇稳态中起重要作用的假说。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验